Clinical Ramifications of Pneumococcal Vaccine Development

Video

Dr. Luwy Musey, executive director in biologics, Merck Research Laboratories, discusses what clinicians need to know about the latest PCVs.

Segment Description: Dr. Luwy Musey, executive director in biologics, vaccine clinical research, Merck Research Laboratories, discusses what clinicians need to know about the latest PCVs.

Part 1: Developments in Pneumococcal Conjugate Vaccines

Recent Videos
Related Content
COVID and Influenza Vaccinations Well Tolerated Whether Given Simultaneously or Sequentially

COVID and Influenza Vaccinations Well Tolerated Whether Given Simultaneously or Sequentially

Kenneth Bender, PharmD, MA
November 19th 2024
Article
From Pathogen to Infectious Disease Diagnosis: Taking on Potential Standard-of-Care Diagnostic Opportunities

From Pathogen to Infectious Disease Diagnosis: Taking on Potential Standard-of-Care Diagnostic Opportunities

Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc
August 1st 2024
Podcast
Trends in Carbapenemase-Producing Organisms: Prevalence, Treatment, and Outcomes

Trends in Carbapenemase-Producing Organisms: Prevalence, Treatment, and Outcomes

Sophia Abene;Kirby An, PharmD
November 7th 2024
Article
From Pathogen to Infectious Disease Diagnosis

From Pathogen to Infectious Disease Diagnosis

Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc
July 12th 2024
Podcast
INSPIRE Trials: Reducing Antibiotic Prescribing For Skin and Soft Tissue And Abdominal Infections

INSPIRE Trials: Reducing Antibiotic Prescribing For Skin and Soft Tissue And Abdominal Infections

Sophia Abene;Shruti K. Gohil, MD, MPH
November 6th 2024
Article
Photohydrolysis Technology Achieves Reduction in Fungal Colony-Forming Units and C auris In Hospital Settings

Photohydrolysis Technology Achieves Reduction in Fungal Colony-Forming Units and C auris In Hospital Settings

Sophia Abene;Deborah (Debbi) Birx, MD;Amy Carenza, BBA
November 5th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.